Moreover, treatment with MG132 further enhanced the increase of MCL1 mediated by FBXW7 siRNA in AML cells after STM2457 treatment (Fig. 4O and Supplementary Fig. S8I). Here, FBXW7 is linked to acute myeloid leukemia.